Drug Shortage Report for LOVASTATIN

Last updated on 2024-03-02 History
Report ID 103759
Drug Identification Number 02353237
Brand name LOVASTATIN
Common or Proper name LOVASTATIN
Company Name SANIS HEALTH INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) LOVASTATIN
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-10-01
Actual start date 2021-05-14
Estimated end date Unknown
Actual end date 2024-03-01
Shortage status Resolved
Updated date 2024-03-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1 PRESIDENTS CHOICE CIRCLE
BRAMPTON, ONTARIO
CANADA L6Y 5S5
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2024-03-02 English Compare
v13 2024-03-01 French Compare
v12 2024-03-01 English Compare
v11 2021-05-15 English Compare
v10 2021-05-14 French Compare
v9 2021-05-14 English Compare
v8 2021-05-13 French Compare
v7 2021-05-13 English Compare
v6 2021-05-08 English Compare
v5 2021-05-07 French Compare
v4 2021-05-07 English Compare
v3 2021-01-13 English Compare
v2 2020-01-21 French Compare
v1 2020-01-21 English Compare

Showing 1 to 14 of 14